The prestigious Picchi Awards, supported by the Picchi Brothers Foundation, aims to inspire and encourage the next generation of cancer research leaders.
Three outstanding PhD students have been chosen from the categories of basic science, clinical science and population health. Each award winner receives $10,000 to learn and build networks; providing support towards research independence.
The awards are available to PhD students who have confirmed candidature at a University affiliated with a VCCC alliance partner and are undertaking cancer-related research training within a VCCC alliance partner at the application closing date.
Basic Science: Stefan Bjelosevic, Peter MacCallum Cancer Centre Investigating FMS-like tyrosine kinase 3 (FLT3)-induced metabolic reprogramming in acute myeloid leukaemia
Clinical Science: Deborah Meyran, Peter MacCallum Cancer Centre New CAR-T cells to enhance paediatric immunotherapy
Population Health: Matthew Grant, St Vincent’s Hospital, Palliative Nexus Research Group, University of Melbourne An exploration of informal communities in cancer treatment
Basic Science:Amanda Oliver, Peter MacCallum Cancer Centre Tissue-specific tumour microenvironments and their impact on immunotherapy responses
Clinical Science:Edward Chew, Walter and Eliza Hall Institute Identification of novel genetic drivers in the development of acute myeloid leukemia
Population Health:Sibel Saya, University of Melbourne The acceptability, feasibility and clinical utility of a genomic profile to target screening for colorectal cancer
Basic Science: Ms Simone Park, University of Melbourne - Doherty Institute The role of tissue-resident memory T cells in melanoma immune surveillance
Clinical Science: Dr Jonathan Hiller, Peter MacCallum Cancer Centre Exploring perioperative adjunctive therapies that can be utilised during cancer surgery to improve cancer outcomes
Population Health: Dr Shuai Li, University of Melbourne DNA methylation and breast cancer risk factors: insights from twin and family studies
Basic Science: Rebecca Delconte, Walter and Eliza Hall Institute and University of Melbourne Targeting Regulators of Natural Killer Cell Homeostasis in Cancer Immunotherapy
Clinical Science: Kathryn Field, Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne Towards the further understanding of prognosis and outcomes for patients with high grade gliomas: A randomised phase II study of Carboplatin and Bevacizumab in Recurrent Glioblastoma (CABARET study)
Population Health: Kevin Nguyen, University of Melbourne Breast Cancer Associations with Mammographic Density Defined by Higher Pixel Brightness Thresholds